MicroRNA-139-5p inhibits bladder cancer proliferation and self-renewal by targeting the Bmi1 oncogene

Bladder Cancer Incidence and Mortality: A Global Overview and Recent Trends

(2017) Sebastien Antoni et al.   EUROPEAN UROLOGY

Antibody-dependent cellular cytotoxicity toward neuroblastoma enhanced by activated invariant natural killer T cells

(2016) Naoko Mise et al.   CANCER SCIENCE

MiR-139-5p is Increased in the Peripheral Blood of Patients with Prostate Cancer

(2016) Cheng Pang et al.   CELLULAR PHYSIOLOGY AND BIOCHEMISTRY

Reanalysis of microRNA expression profiles identifies novel biomarkers for hepatocellular carcinoma prognosis

(2016) Zhengqiang Wang et al.   TUMOR BIOLOGY

A modified method by differential adhesion for enrichment of bladder cancer stem cells

(2016) Yong-tong Zhu et al.   International Braz J Urol

miR-139-5p regulates proliferation, apoptosis, and cell cycle of uterine leiomyoma cells by targeting TPD52

(2016) Hong Chen et al.   OncoTargets and Therapy

A gain-of-function ACTC1 3′UTR mutation that introduces a miR-139-5p target site may be associated with a dominant familial atrial septal defect

(2016) Ye Wang et al.   Scientific Reports

miR-139-5p inhibits epithelial–mesenchymal transition, migration and invasion of hepatocellular carcinoma cells by targeting ZEB1 and ZEB2

(2015) Gongcai Qiu et al.   BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS

Knockdown of Bmi1 inhibits bladder cancer cell growth both in vitro and in vivo by blocking cell cycle at G1 phase and inducing apoptosis

(2015) Hong-bo Luo et al.   Journal of Huazhong University of Science and Technology-Medical Sciences

MiR-139-5p: promising biomarker for cancer

(2015) He-da Zhang et al.   TUMOR BIOLOGY

MiR-139-5p inhibits migration and invasion of colorectal cancer by downregulating AMFR and NOTCH1

(2014) Mingxu Song et al.   Protein & Cell

Tumor-Suppressive Function of miR-139-5p in Esophageal Squamous Cell Carcinoma

(2013) Ran Liu et al.   PLoS One

miR-139-5p is a regulator of metastatic pathways in breast cancer

(2013) K. Krishnan et al.   RNA

MiR-139 inhibits invasion and metastasis of colorectal cancer by targeting the type I insulin-like growth factor receptor

(2012) Ke Shen et al.   BIOCHEMICAL PHARMACOLOGY

Bmi1 Is Required for Hepatic Progenitor Cell Expansion and Liver Tumor Development

(2012) Lingling Fan et al.   PLoS One

The MicroRNA miR-139 Suppresses Metastasis and Progression of Hepatocellular Carcinoma by Down-regulating Rho-Kinase 2

(2010) Carmen Chak–Lui Wong et al.   GASTROENTEROLOGY

Bmi1 Functions as an Oncogene Independent of Ink4A/Arf Repression in Hepatic Carcinogenesis

(2009) C.-R. Xu et al.   MOLECULAR CANCER RESEARCH

MicroRNAs as potential cancer therapeutics

(2009) P Trang et al.   ONCOGENE